By Denny Jacob Avenue Therapeutics Inc. shares jumped 30% to $1.49 in aftermarket trading Monday after receiving minutes from a meeting with the Food and Drug Administration, which it said. | April 17, 2023
Avenue Therapeutics Shares Jump 30% on FDA Meeting Minutes morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
30.03.2023 - MIAMI, March 30, 2023 (GLOBE NEWSWIRE) - Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and .
Avenue Therapeutics (ATXI) will participate in a Type C meeting with the FDA on March 9 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.